Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Zevenbergen Innovative Growth Stock Fund. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+1.13%
YTD+6.55%
Annualized+11.85%
Positioning StanceCONSTRUCTIVE
Market CapAll Cap
GeographyUS
Digest Analysis
Quick Take
"Expanding corporate profits and moderating valuation multiples indicate solid foundations for secular growth equities as artificial intelligence applications broaden beyond foundational infrastructure into commercial software, robotics, and aerospace."
Executive Summary
The Virtus Zevenbergen Innovative Growth Stock Fund posted a net return of 1.13% for Class I shares in the third quarter of 2026, outpacing the Russell 3000 Growth Index's 0.45% net return. On a year-to-date basis, the fund gained 6.55% net of fees compared to 6.36% for the benchmark. Performance during the period was spearheaded by healthcare diagnostics and commerce software, which mitigated performance drag stemming from space technology, autonomous vehicles, and data center connectivity infrastructure.
Macroeconomic headwinds included renewed Middle East geopolitical tensions pushing crude oil past $100 per barrel, sustained elevated inflation, and an unexpected Federal Reserve rate hike in September that drove long-term Treasury yields to multi-decade highs. While broad market leadership narrowed and rate-sensitive small-cap equities suffered sharp pullbacks, corporate earnings displayed resilience across growth sectors. The investment team noted that corporate earnings growth outpaced share price gains, lowering the forward price-to-earnings multiple of large-cap benchmarks beneath five-year historical averages.
Portfolio activity and contribution were led by Natera and Shopify, supported by solid demand in oncology monitoring and resilient commerce volumes. Detractors included Rocket Lab, which digested broader post-IPO sector sentiment and fiscal budget uncertainty despite record backlog, and Credo Technology Group, which faced hardware multiple compression despite 115% top-line growth. Top fund allocations remain anchored in secular leaders including NVIDIA, Tesla, Advanced Micro Devices, and Shopify.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
82%
CautiousHigh
High Conviction (82%)
Portfolio construction exhibits high concentration, with the top ten equity holdings accounting for over 54% of total assets, led by NVIDIA at 9.08% and Tesla at 6.63%. The investment team articulates detailed, multi-year fundamental theses across key individual holdings while explicitly reiterating a commitment to remain invested through market volatility.
Growth Outlook
65%
BearishBullish
Bullish (65%)
Management recognizes near-term headwinds such as elevated borrowing costs, midterm election uncertainty, and persistent inflation, yet highlights that corporate earnings growth outpaced equity prices to pull forward P/E ratios below their five-year averages. The broader perspective is constructive, underwritten by widening operational applications for secular technologies.
Risk Appetite
75%
DefensiveAggressive
Aggressive (75%)
Positioning remains firmly oriented toward growth and innovation equities, fully allocated to high-beta technology, consumer internet, and aerospace enterprises without building defensive hedges or raising outsized cash. The manager maintains conviction in volatile names including Rocket Lab and Credo Technology Group despite recent share pullbacks.
Capital Deployment
55%
De-riskingDeploying
Net Neutral (55%)
The portfolio maintained a stable asset allocation posture during the quarter, neither raising elevated cash nor engaging in wholesale defensive de-risking. Core capital remains fully committed across existing high-conviction positions.
Forward Guidance
70%
CautiousExpansionary
Expansionary (70%)
The manager advocates remaining invested as compound earnings growth materializes rather than trading tactical macro headlines. The strategy is poised to selectively capture opportunities as the AI cycle broadens into enterprise software, robotics, and space infrastructure.
Language Signal
72%
BearishBullish
Bullish (72%)
Constructive commentary around corporate earnings power, robust contract backlogs, and multi-year product runway outweighs references to macro inflation and yield volatility. Discussions of company fundamentals emphasize expanding margins and outsized growth potential through 2030.
Perceived Risk
60%
Low RiskElevated
Moderate Risk (60%)
Macroeconomic risks are discussed in detail, specifically crude oil surging above $100 amid renewed geopolitical friction, multi-decade high Treasury yields, and election-related government budget visibility concerns. These headwinds are balanced against improving equity valuation multiples and corporate profit resilience.
Opportunity Density
72%
ScarceAbundant
Abundant (72%)
Secular growth opportunities are expanding beyond foundational semiconductor infrastructure into enterprise workflow software, aerospace, robotics, and molecular diagnostics. The team identifies attractive risk/reward setups in businesses of diverse market capitalizations where competitive positions are compounding.
Time Horizon
85%
Short-TermLong-Term
Decade+ (85%)
Investment philosophy explicitly disfavors trading on headline volatility in favor of underwriting durable compounding over multi-year periods. Positions such as Credo are evaluated on targets extending through 2030, while diagnostic adoption cycles are framed through 2027 and beyond.